Maven Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
+24,800
New +$13.5M 0.23% 89
2025
Q1
Sell
-1,322
Closed -$716K 978
2024
Q4
$688K Buy
1,322
+8
+0.6% +$4.4K 0.02% 503
2024
Q3
$813K Buy
+1,314
New +$778K 0.02% 553
2024
Q2
Sell
-349
Closed -$200K 1008
2024
Q1
$203K Buy
+349
New +$196K 0.01% 324
2023
Q4
Sell
-605
Closed -$293K 1201
2023
Q3
$306K Sell
605
-506
-46% -$270K ﹤0.01% 944
2023
Q2
$580K Buy
+1,111
New +$600K 0.01% 583
2022
Q2
Sell
-1,878
Closed -$1.11M 1108
2022
Q1
$1.11M Buy
+1,878
New +$1.08M 0.04% 309
2021
Q4
Sell
-4,002
Closed -$2.29M 1147
2021
Q3
$2.29M Sell
4,002
-2,840
-42% -$1.56M 0.07% 206
2021
Q2
$3.45M Buy
+6,842
New +$3.23M 0.14% 126
2021
Q1
Sell
-1,356
Closed -$632K 1295
2020
Q4
$632K Buy
+1,356
New +$636K 0.06% 314

Other funds holding TMO

Maven Securities's TMO Position: Q1 2026 in Review

Maven Securities opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 24,800 shares worth $12.2M. The stake represents 0.23% of the portfolio and ranks #89 among its holdings. This is a return to the name: Maven Securities previously reported a position in TMO as recently as Q4 2024.

Maven Securities first reported a position in TMO in Q4 2020 and has held it in 10 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Maven Securities held 24,800 shares of Thermo Fisher Scientific worth $12.2M as of Q1 2026.
  • Thermo Fisher Scientific was a new Maven Securities position in Q1 2026.
  • Thermo Fisher Scientific made up 0.23% of Maven Securities's portfolio in Q1 2026, its #89 holding.
  • Maven Securities first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 10 quarters since.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.